Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT00683332 Completed - Clinical trials for Complicated Intra-abdominal Infections

Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)

Start date: April 2007
Phase: N/A
Study type: Observational

The purpose of this study is to collect post-marketing information on the safety of Tygacil in Filipino patients.

NCT ID: NCT00680485 Terminated - Bacterial Infection Clinical Trials

Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416

Start date: June 2007
Phase: Phase 1
Study type: Interventional

This study will evaluate the safety, tolerability and exposure of repeat escalating oral doses, a loading dose/maintenance dose regimen of GSK580416 and when co administered with ketoconazole, a PGP/CYP3A4 inhibitor.

NCT ID: NCT00680459 Terminated - Clinical trials for Bloodstream Infection

Ethanol Locks for the Treatment of Central Venous Line Infections

Start date: May 2008
Phase: Phase 3
Study type: Interventional

Ethanol Locks as an Adjunct Treatment for Central Venous Line Infections Purpose To evaluate the effectiveness of a 70% ethanol lock solution when used as an adjunct therapy with antibiotics to treat central venous line infections Study Design Randomized Controlled Trial Study Protocol Only those patients meeting all inclusion criteria and no exclusion criteria will be eligible to participate in this study. Once identified, signed informed consent will be obtained from the patient's guardian and the patient himself/herself depending on age. Patients will be randomized into 2 groups: Group 1 - those patients who will receive ethanol lock therapy and Group 2- those patients who will receive placebo therapy in the form of a heparin lock solution. Outcome Measures Treatment success as defined by- - Clearance of the infection as documented by negative blood cultures on day 6 (one day after completed of lock treatment) - Preservation of the line at 30 days post treatment (day 35 of the study), this will be documented by a chart review in CIS and telephone interview to ensure no further growth from blood cultures or infections Treatment failure as defined by- - Clinical worsening during treatment - Removal of the line due to persistent infection or sepsis - Recurrence of infection with the same pathogen within 30 days

NCT ID: NCT00679835 Completed - Clinical trials for Gram Positive Infection

PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections

Start date: June 3, 2008
Phase: Phase 1
Study type: Interventional

This is a research study designed to look at the pharmacokinetics (distribution, breakdown, and removal) and tolerability of a single dose of daptomycin in patients aged 2 to 6 years who have infections that are caused by a specific group of bacteria (called Gram-positive bacteria).

NCT ID: NCT00679497 Completed - HIV Infections Clinical Trials

A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection

RisVac02
Start date: June 2008
Phase: Phase 1
Study type: Interventional

The purpose of this clinical trial is to study a modified pox viral vector considering: 1. HIV subtype B accounts for the most frequent virus strain in Europe and North America, as well as in many parts of the world. 2. This novel vaccinia construct expressing HIV subtype B gag, pol, env and nef antigens is to be studied in humans for the first time.

NCT ID: NCT00679302 Completed - Clinical trials for Skin Diseases, Infectious

Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management

Start date: July 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if antibiotics are required in the management of skin abscess following incision and drainage.

NCT ID: NCT00678106 Completed - Clinical trials for Bacterial Infections

Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections

Start date: September 2008
Phase: Phase 1
Study type: Interventional

Adolescent subjects hospitalized for the treatment of bacterial infections will be given 1 gram of dalbavancin through their veins and levels of dalbavancin in blood and urine will be measured at different time points. Safety labs will also be checked on a regular basis to assess the safety of dalbavancin.

NCT ID: NCT00678041 Terminated - Clinical trials for Urinary Tract Infections

Nitrofurantoin and Urinary Tract Infections (UTIs)

APPIC
Start date: May 2008
Phase: N/A
Study type: Interventional

Urinary tract infection (UTI) is the most common complication after surgery for prolapse or urinary incontinence. UTIs are painful and have the potential to turn into kidney infections. We are asking women who self-catheterize after surgery to try either an antibiotic or a placebo pill so we can see if we can prevent UTIs without causing side effects. This study will not require any additional visits or blood draws. You will be asked to answer some questions, keep a brief diary of your experience, and immediately report any symptoms of a UTI to your doctor.

NCT ID: NCT00678028 Completed - Clinical trials for Recurrent Urinary Tract Infections

Association Between Deficiency of MBL (Mannose-Binding Lectin) and Polymorphisms in MBL2 Gene to Urinary Tract Infection

Start date: February 2008
Phase: N/A
Study type: Observational

Due to genetic polymorphism about 15%-30% of the world population have low levels of MBL (Mannose Binding Lectin) in serum (below 500ng/mL). Different studies reported correlation between polymorphism in the MBL gene with low levels of MBL in serum and higher frequency of recurrent infections, severity of sepsis, ARDS and other infections. Urinary Tract Infection (UTI) is one of the very common infection in women. Since MBL is part of the innate immunity and there are proofs of relation between patients with recurrent infections and lack of MBL, we decided to explore a possible relation between low levels of MBL and different genotypes of MBL in young women and the risk to develop recurrent UTI.

NCT ID: NCT00677131 Completed - Infection Clinical Trials

Study of the Evaluation of Patient Education Efficacy in Pharmacy of National Taiwan University Hospital

Start date: April 2008
Phase: N/A
Study type: Interventional

The primary purpose of this study is to evaluate the patient education efficacy of the pharmacists in National Taiwan University Hospital. We randomize patient family into one of the following three groups: 1. To read the package insert of the drug 2. To read the education information provided by Pharmacy of NTUH 3. Oral education provided by the pharmacist Then we will evaluate the difference on patient knowledge of reconstitution, storage, and administration of oral antibiotic suspension from powder dosage form between these three groups.